EMBRYOAGENT
"EMBRYOAGENT" is a word and design mark owned by Fertilys Innovation Inc., filed at the USPTO on October 23, 2026. It is under examination and covers classes 9, 42 and 44.
- Status
- Under examination
- Since October 23, 2026
- Filed
- October 23, 2026
- Registered
- Not yet
- Priority date
- October 6, 2026
- Claimed from Canada
- Application no.
- 50178131
- Registration no.
- Not yet
- Office
- USPTO
- United States Patent and Trademark Office
- Mark type
- Word and design
- 3 classes
Who owns EMBRYOAGENT
The owner and representative on file with the office.
Owner
Fertilys Innovation Inc.
Laval, Canada
Representative
Alexander P. Montgomery
Hinckley, Allen & Snyder, LLP
What the mark covers
The products and services EMBRYOAGENT is filed for, grouped by Nice class.
downloadable computer software using artificial intelligence for analyzing images of human eggs at all stages of development, and embryos, to assess the quality of human eggs and embryos; downloadable computer software using artificial intelligence for ranking human embryos for selection for transfer in fertility treatment; downloadable computer software using artificial intelligence for analyzing the development of human eggs and embryos over time; downloadable computer software using artificial intelligence for analyzing medical, biological and developmental data relating to human eggs and embryos in the field of assisted reproduction; downloadable computer software using artificial intelligence for analyzing genomic and chromosomal data of human embryos for use in assisted reproduction; downloadable computer software using artificial intelligence for predicting fertility treatment outcomes, namely, embryo ploidy, embryo implantation, pregnancy and live birth; downloadable computer software for use by embryologists and fertility clinics for managing, viewing and comparing embryo assessment data and for decision support in embryo selection; downloadable machine learning models for assessing human eggs and embryos in the field of assisted reproduction; recorded computer software using artificial intelligence for analyzing images and data of human eggs and embryos for use in assisted reproduction
providing temporary use of online non downloadable software using artificial intelligence for analyzing images of human eggs and embryos to assess their quality and to rank embryos for selection in fertility treatment; software as a service (SaaS) services featuring artificial intelligence software for analyzing medical, biological, developmental and genomic data of human eggs and embryos; platform as a service (PaaS) featuring artificial intelligence software platforms for embryo assessment, prediction of embryo competence and prioritization of embryos in the field of assisted reproduction; scientific research in the field of assisted reproduction; scientific research in the fields of embryology and reproductive genomics; medical and scientific research in the field of predicting embryo ploidy and embryo competence; research and development of artificial intelligence and machine learning models in the field of assisted reproduction; design and development of computer software in the field of embryo assessment and assisted reproduction; technological consulting in the field of artificial intelligence software for assisted reproduction; technological consulting services in the field of integrating imaging, clinical and genomic data for embryo assessment; analysis of genomic data of human embryos for scientific research purposes; Hosting of databases of embryo imaging, clinical and genomic data for others
medical analysis services in the field of assisted reproduction, namely, assessment, grading and ranking of human eggs and embryos; medical services, namely, embryo selection services for in vitro fertilization; providing medical information in the field of assisted reproduction and embryo assessment; medical consulting services in the field of in vitro fertilization and embryo selection
What has happened so far
Steps recorded by the USPTO, newest first.
- Application filing receipt mailed
- New application entered
About EMBRYOAGENT
Who owns the trademark "EMBRYOAGENT"?
The USPTO trademark "EMBRYOAGENT" (application 50178131) is owned by Fertilys Innovation Inc.
What is the status of "EMBRYOAGENT"?
Its status at the USPTO is: under examination.
Get this data via the API
Everything on this page comes from the Signa API. Pull EMBRYOAGENT and marks like it into your own product with one request.
GET/v1/trademarks/{id}The full record: owners, classes, dates and images
GET/v1/trademarks/{id}/eventsEvery step in the office history
GET/v1/proceedings?trademark_id={id}Oppositions and cancellations against the mark
ID=tm_01a16e03-c085-7551-9895-7b68156bd16f
curl https://api.signa.so/v1/trademarks/$ID \
-H "Authorization: Bearer $SIGNA_API_KEY"{
"id": "tm_01a16e03-c085-7551-9895-7b68156bd16f",
"object": "trademark",
"mark_text": "EMBRYOAGENT",
"status": {
"primary": "pending",
"stage": "examining"
},
"office_code": "US",
"application_number": "50178131",
"filing_date": "2026-10-23",
"nice_classes": [
9,
42,
44
],
"owners": [
{
"name": "Fertilys Innovation Inc.",
"entity_id": null
}
]
}